Published in Cerebrovasc Brain Metab Rev on January 01, 1992
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A (2001) 2.73
Adenosine A3 receptor stimulation and cerebral ischemia. Eur J Pharmacol (1994) 2.33
Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res (2013) 1.68
Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A (1995) 1.62
Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal (2005) 1.58
The resurgence of A2B adenosine receptor signaling. Biochim Biophys Acta (2010) 1.23
Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils. Eur J Pharmacol (1996) 1.11
Activity-dependent release of adenosine: a critical re-evaluation of mechanism. Curr Neuropharmacol (2008) 1.11
A2B adenosine receptor-mediated induction of IL-6 promotes CKD. J Am Soc Nephrol (2011) 1.07
Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist. Eur J Pharmacol (1995) 1.02
Adenosine Release Evoked by Short Electrical Stimulations in Striatal Brain Slices is Primarily Activity Dependent. ACS Chem Neurosci (2010) 0.97
Measurement of purine release with microelectrode biosensors. Purinergic Signal (2011) 0.92
Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist. Eur J Pharmacol (1996) 0.92
Adenosine: a prototherapeutic concept in neurodegeneration. Ann N Y Acad Sci (1995) 0.92
Mechanical stimulation evokes rapid increases in extracellular adenosine concentration in the prefrontal cortex. J Neurochem (2014) 0.92
Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br J Pharmacol (2002) 0.91
Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI. Epilepsy Res (2010) 0.90
Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist. Eur J Pharmacol (1999) 0.89
Neuroadaptations in adenosine receptor signaling following long-term ethanol exposure and withdrawal. Alcohol Clin Exp Res (2011) 0.88
Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in rat hippocampus. Eur J Neurosci (2007) 0.88
Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders. Ann N Y Acad Sci (1997) 0.88
AM-36 modulates the neutrophil inflammatory response and reduces breakdown of the blood brain barrier after endothelin-1 induced focal brain ischaemia. Br J Pharmacol (2006) 0.86
Involvement of peripheral adenosine A2 receptors in adenosine A1 receptor-mediated recovery of respiratory motor function after upper cervical spinal cord hemisection. J Spinal Cord Med (2006) 0.83
Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea. J Neurosci (2016) 0.83
Hypoxic changes in rat locus coeruleus neurons in vitro. J Physiol (1995) 0.82
Modification of adenosine modulation of synaptic transmission in the hippocampus of aged rats. Br J Pharmacol (2000) 0.82
Regulation of adenosine levels during cerebral ischemia. Acta Pharmacol Sin (2012) 0.79
Acute pulmonary embolism decreases adenosine plasma levels in anesthetized pigs. ISRN Cardiol (2011) 0.78
Block by N6-L-phenylisopropyl-adenosine of the electrophysiological and morphological correlates of hippocampal ischaemic injury in the gerbil. Br J Pharmacol (1996) 0.77
Ultrasound stimulates formation and release of vasoactive compounds in brain endothelial cells. Am J Physiol Heart Circ Physiol (2015) 0.76
Multiple pathways for elevating extracellular adenosine in the rat hippocampal CA1 region characterized by adenosine sensor cells. J Neurochem (2016) 0.75
Modulation of visual inputs to accessory optic system by theophylline during hypoxia. Exp Brain Res (2006) 0.75
Tissue engineering of a differentiated cardiac muscle construct. Circ Res (2002) 4.50
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A (2001) 2.73
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol (1998) 2.43
Cytotoxicity of microglia. Glia (1993) 2.29
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 2.23
How does adenosine inhibit transmitter release? Trends Pharmacol Sci (1988) 2.20
A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal Biochem (1990) 2.11
Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedebergs Arch Pharmacol (1976) 2.09
The birth and postnatal development of purinergic signalling. Acta Physiol (Oxf) (2010) 2.06
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer (2006) 1.91
Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol (1980) 1.81
Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther (2001) 1.81
Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol (1999) 1.76
Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) (2007) 1.71
Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol (1982) 1.62
On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors. Acta Pharmacol Toxicol (Copenh) (1979) 1.58
On the central sites for the antinociceptive action of morphine and fentanyl. Neuropharmacology (1970) 1.57
Adenosine increases LPS-induced nuclear factor kappa B activation in smooth muscle cells via an intracellular mechanism and modulates it via actions on adenosine receptors. Acta Physiol (Oxf) (2013) 1.42
Inhibition of sodium-linked glucose reabsorption normalizes diabetes-induced glomerular hyperfiltration in conscious adenosine A₁-receptor deficient mice. Acta Physiol (Oxf) (2013) 1.40
Adenosine-dopamine interactions in the brain. Neuroscience (1992) 1.39
Adenosine signaling and function in glial cells. Cell Death Differ (2009) 1.39
The release of adenosine and inosine from canine subcutaneous adipose tissue by nerve stimulation and noradrenaline. J Physiol (1981) 1.39
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A (1991) 1.39
Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci (1992) 1.38
Adenosine receptors. Med Biol (1982) 1.37
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.35
Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci Lett (1982) 1.34
Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides. Trends Pharmacol Sci (1997) 1.33
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A (2000) 1.30
Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience (1998) 1.29
Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett (1985) 1.29
Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol Pharmacol (2000) 1.29
Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur J Pharmacol (1988) 1.28
Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol Pharmacol (2000) 1.27
Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand (1991) 1.27
Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5'-nucleotidase and adenosine deaminase. Biochem Pharmacol (1978) 1.27
Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci (1996) 1.25
Isomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin. Biochim Biophys Acta (1976) 1.25
Inhibitory effect of adenosine on adrenergic neuroeffector transmission in the rabbit heart. Acta Physiol Scand (1979) 1.23
Pharmacology of adenosine A2A receptors. Trends Pharmacol Sci (1996) 1.23
ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line. J Biol Chem (1992) 1.23
Experimental approach to test the role of actin in axonal transport. Brain Res (1980) 1.21
Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem Int (1993) 1.21
Adenosine analogues depress ventilation in rabbit neonates. Theophylline stimulation of respiration via adenosine receptors? Pediatr Res (1984) 1.21
Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J Pharmacol Exp Ther (1989) 1.20
Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res (1978) 1.19
Adenosine receptors mediating cyclic AMP production in the rat hippocampus. J Neurochem (1982) 1.19
Caffeine--an atypical drug of dependence. Drug Alcohol Depend (1998) 1.19
On the mechanism of action of theophylline and caffeine. Acta Med Scand (1985) 1.18
Synthetic peptides derived from the Listeria monocytogenes p60 protein as antigens for the generation of polyclonal antibodies specific for secreted cell-free L. monocytogenes p60 proteins. Appl Environ Microbiol (1994) 1.18
Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res (1994) 1.17
A novel 8-phenyl-substituted xanthine derivative is a selective antagonist at adenosine A1-receptors in vivo. Acta Physiol Scand (1985) 1.16
Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand (1985) 1.15
Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience (1997) 1.14
Localization of adenosine receptor messenger RNAs in the rat eye. Exp Eye Res (1997) 1.13
Differential effect of adenosine on pre- and postsynaptic calcium fluxes. Brain Res (1986) 1.11
Analysis and quantitative evaluation of the depressive effect of adenosine on evoked potentials in hippocampal slices. Brain Res (1979) 1.10
Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience (2002) 1.09
Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse (1997) 1.09
Adenosine receptors mediating inhibitory electrophysiological responses in rat hippocampus are different from receptors mediating cyclic AMP accumulation. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.08
Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol Scand (1982) 1.07
Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochem Pharmacol (1999) 1.07
Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem Int (1995) 1.06
The anticonvulsive action of adenosine: a postsynaptic, dendritic action by a possible endogenous anticonvulsant. Brain Res (1984) 1.06
Ischemia-induced neuronal cell death, calcium accumulation, and glial response in the hippocampus of the Mongolian gerbil and protection by propentofylline (HWA 285). J Cereb Blood Flow Metab (1987) 1.06
Permeation of tetracyclines through membranes of liposomes and Escherichia coli. Eur J Biochem (2000) 1.06
Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors. Acta Physiol (Oxf) (2007) 1.05
Stimulation of adenosine A1 receptors and bradykinin receptors, which act via different G proteins, synergistically raises inositol 1,4,5-trisphosphate and intracellular free calcium in DDT1 MF-2 smooth muscle cells. Proc Natl Acad Sci U S A (1992) 1.05
Theophylline actions on adenosine receptors. Eur J Respir Dis Suppl (1980) 1.05
An A1-adenosine receptor, characterized by [3H] cyclohexyladenosine binding, mediates the depression of evoked potentials in a rat hippocampal slice preparation. Neurosci Lett (1982) 1.05
The use of in vitro brain slices for multidisciplinary studies of synaptic function. Annu Rev Neurosci (1980) 1.04
Adenosine, adenosine A 2A antagonists, and Parkinson's disease. Parkinsonism Relat Disord (2009) 1.04
Isolation of catalase-negative Listeria monocytogenes strains from listeriosis patients and their rapid identification by anti-p60 antibodies and/or PCR. J Clin Microbiol (1997) 1.04
Studies on the oxygen radical mechanism involved in the small intestinal reperfusion damage. Acta Physiol Scand (1985) 1.02
Characterization of adenosine receptors in isolated cerebral arteries of cat. Br J Pharmacol (1983) 1.02
Cyclic AMP independent inhibition by papaverine of histamine release induced by compound 48/80. Biochem Pharmacol (1976) 1.02
Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.02
The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci (1999) 1.02
Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells. Mol Pharmacol (1990) 1.02
Cytochemical localization of 5'-nucleotidase in glial plasma membranes. Brain Res (1978) 1.02
Cardiovascular effects of adenosine. Clin Physiol (1986) 1.01
Tet repressor induction without Mg2+. Biochemistry (2000) 1.00
Release of endogenous and radioactive purines from the rabbit retina. Brain Res (1986) 1.00
Stimulation-dependent release of 3H-adenosine derivatives from central axon terminals to target neurones. Nature (1976) 1.00
A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment. Brain Res (1997) 1.00
Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors. Naunyn Schmiedebergs Arch Pharmacol (1996) 1.00
Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience (1999) 1.00
Determinants of protein-protein recognition by four helix bundles: changing the dimerization specificity of Tet repressor. EMBO J (1998) 0.99
Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J Neurosci (1995) 0.99
Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J Pharmacol Exp Ther (1993) 0.99
Excitation and axonal flow: autoradiographic study on motoneurons intracellularly injected with a 3H-amino acid. Exp Brain Res (1970) 0.99
Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.99
Levels of adenosine and adenine nucleotides in slices of rat hippocampus. Brain Res (1984) 0.98
Differential regulation of microglial activation by propentofylline via cAMP signaling. Brain Res (1998) 0.98
Adenosine and neuropeptide Y enhance alpha 1-adrenoceptor-induced accumulation of inositol phosphates and attenuate forskolin-induced accumulation of cyclic AMP in rat vas deferens. Neurosci Lett (1987) 0.98
Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction. Kidney Int (2006) 0.98
Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. Brain Res (1993) 0.98
Some aspects of the electroanatomy of dendrites. Adv Neurol (1975) 0.98